Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000182396 | SCV000234739 | pathogenic | not provided | 2019-05-07 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 28333919) |
Institute of Medical Genetics and Applied Genomics, |
RCV000182396 | SCV001447471 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001852314 | SCV002232722 | pathogenic | Charcot-Marie-Tooth disease type 2 | 2024-01-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp467*) in the LMNA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LMNA are known to be pathogenic (PMID: 18585512, 18926329). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of LMNA-related conditions (PMID: 28333919). ClinVar contains an entry for this variant (Variation ID: 200965). For these reasons, this variant has been classified as Pathogenic. |
Sangiuolo Lab - |
RCV001775092 | SCV001593113 | pathogenic | Dilated cardiomyopathy 1A | 2021-04-27 | no assertion criteria provided | clinical testing |